The prevalence of diabetes mellitus increases markedly with age. Furth
ermore, advancing age is a strong risk factor for diabetic neuropathy,
independent of the duration of diabetes mellitus and glycaemic contro
l. Several biological changes occurring during the aging process may a
ccount for the facilitating effect of age on diabetic neuropathy. Thes
e include an increase in the production of advanced glycosylation end-
products (AGEs), a defect in the polyol pathway, nerve vascular altera
tions and impaired resistances to oxidative stress. The clinical diagn
osis of diabetic neuropathy is often difficult in elderly patients. Th
e relationship between symptoms and neuropathy and that between neurop
athy and diabetes mellitus are more difficult to ascertain in elderly
patients due to age-related changes in the peripheral and autonomic ne
rvous system and associated diseases frequently encountered in this po
pulation. Diagnosis of diabetic neuropathy is based on nerve conductio
n studies, vibratory perception threshold determination and assessment
of autonomic function. For most of these tests, reference values are
markedly influenced by age and their interpretation should use careful
ly age-adjusted reference intervals.